Einat Brill Almon
2013
In 2013, Einat Brill Almon earned a total compensation of $933.1K as Senior Vice President, Product Development at Protalix BioTherapeutics, a 35% decrease compared to previous year.
Compensation breakdown
| Bonus | $100,000 |
|---|---|
| Option Awards | $126,208 |
| Salary | $261,505 |
| Stock Awards | $378,745 |
| Other | $66,600 |
| Total | $933,058 |
Almon received $378.7K in stock awards, accounting for 41% of the total pay in 2013.
Almon also received $100K in bonus, $126.2K in option awards, $261.5K in salary and $66.6K in other compensation.
Rankings
In 2013, Einat Brill Almon's compensation ranked 6,944th out of 12,286 executives tracked by ExecPay. In other words, Almon earned more than 43.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 6,944 out of 12,286 | 44th |
Division Manufacturing | 2,463 out of 4,612 | 47th |
Major group Chemicals And Allied Products | 745 out of 1,462 | 49th |
Industry group Drugs | 550 out of 1,156 | 52nd |
Industry Biological Products, Except Diagnostic Substances | 88 out of 196 | 55th |
Source: SEC filing on July 1, 2016.
Almon's colleagues
We found four more compensation records of executives who worked with Einat Brill Almon at Protalix BioTherapeutics in 2013.
2013
David Aviezer
Protalix BioTherapeutics
Chief Executive Officer
2013
Yoseph Shaaltiel
Protalix BioTherapeutics
Executive Vice President, Research and Development
2013
Yossi Maimon
Protalix BioTherapeutics
Chief Financial Officer
2013
Tzvi Palash
Protalix BioTherapeutics